title: A continuous infusion of etoposide and doxorubicin for refractory MAS management.
authors: Department of Haematology, PLA 251 Hospital, Zhang Jia Kou, Hebei, China.
authors: J
authors: J
authors: Jin
mesh_terms: D004317:Doxorubicin / Q000627:therapeutic use*; D005047:Etoposide / Q000627:therapeutic use*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D007262:Infusions, Intravenous; D055501:Macrophage Activation Syndrome / Q000188:drug therapy* / Q000209:etiology; D008775:Methylprednisolone / Q000627:therapeutic use; D016706:Still's Disease, Adult-Onset / Q000150:complications / Q000188:drug therapy; D059005:Topoisomerase II Inhibitors / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D059005:Topoisomerase II Inhibitors; D005047:Etoposide; D004317:Doxorubicin; D008775:Methylprednisolone